about
Tourmaline Bio Inc is a late-stage clinical biotechnology company driven by its mission to develop transformative medicines that dramatically improve the lives of patients with life-altering immune diseases. Its initial product candidate is TOUR006, ...
Read More307.9K XNAS Volume
XNAS 06 May, 2025 5:30 PM (EDT)
Board Meeting
The next board meeting for Tourmaline Bio Inc is on 13 May 2025 for the purpose of Tourmaline Bio Inc First Quarter Earnings Results for 2025
See details
Not Eligible
Expensive Valuation
Technically Bearish
Tourmaline Bio Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..